University of California San Francisco
Give to UCSF
Genetic Test Helps Predict Risk of Prostate Cancer Recurrence
A genetic test that measures cell cycle progression — an indicator of how rapidly cancer cells are growing and dividing — can be a useful tool for predicting who will have a recurrence of prostate cancer, according to researchers at UCSF.
New Prostate Cancer Test Improves Risk Assessment
A new genomic test can help predict whether men are more likely to harbor an aggressive form of prostate cancer, according to a new UCSF study.
President Obama Nominates Mack Roach to National Cancer Advisory Board
<p>President Barack Obama announced his intent to nominate UCSF's Mack Roach, who is recognized as a major authority on the treatment of prostate cancer, to the National Cancer Advisory Board.</p>
Prostate Cancer Dream Team Gets $10 Million Grant to Tackle Advanced Disease
Armed with a new $10 million grant, a multi-center “dream team’’ of scientists, led by UCSF, is embarking on a groundbreaking undertaking to overcome therapeutic resistance and revolutionize treatment for patients with advanced prostate cancer.
Study Confirms Erroneous Link Between Prostate Cancer and Retrovirus from Mice
A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments – some dating back nearly a decade – has confirmed.
Advanced Prostate Cancer Slows With New Drug
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease, according to results of a UCSF-led study.